Achaogen Announces First Quarter 2014 Results

[GlobeNewswire] – SOUTH SAN FRANCISCO, Calif. — Achaogen, Inc. , a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR) gram-negative infections, today reported financial … more

View todays social media effects on AKAO

View the latest stocks trending across Twitter. Click to view dashboard

See who Achaogen is hiring next, click here to view